ArticleRegenerative therapy2026
Investigation of cartilage modification for controlling immune reaction against xenogeneic cartilage.
Article in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Allogeneic cartilages are decellularized when they are transplanted subcutaneously to avoid the immunoreaction in clinical practice. However, transplanting cartilage with chondrocytes would be beneficial because chondrocytes are essential for the maintenance of the cartilage. In this study, we investigated the effect of modifications to cartilage before transplantation for the suppression of immunoreactions. We utilized xenogeneic models because they are often employed in preclinical safety evaluations prior to clinical trials. If xenogeneic immunoreactions can be controlled, allogeneic rejection should be easier to manage. Methods: Cartilaginous particles differentiated from human iPS cells were modified in two ways. For coverage with syngeneic chondrocytes, cartilaginous particles were cocultured with murine chondrocytes for 7 days. For decellularization, particles were undergone freeze & thaw with or without DNase cycles of either 5 or 15. After these modifications, cartilaginous particles were filled in meshed tubular PLA scaffolds and subcutaneously transplanted into C57BL/6-Tg (CAG-EGFP) for 8 weeks. Immunoreactions were histologically evaluated by immunostaining against CD3, CD4 and Foxp3. Results: In vitro studies showed that chondrocytes successfully covered the cartilaginous particle irrespective of decellularization. In addition, decellularization of cartilage was possible without apparent breakdown of the matrix structure. In transplantation experiments, severe immune reactions were not observed histologically. However, CD4 (+) cells and CD3 (+) cells increased when cartilaginous particles received both chondrocyte coverage and decellularization, while Foxp3 (+) cells were not observed. Conclusions: Contrary to our expectations, combination of decellularization and surface coverage of cartilaginous transplants increased T cells, suggesting the complexity of the immunoreaction against xenogeneic cartilages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.